Language
English
Publication Date
12-11-2023
Journal
Cancer Cell
DOI
10.1016/j.ccell.2023.10.002
PMID
37890490
PMCID
PMC11146682
PubMedCentral® Posted Date
6-3-2024
PubMedCentral® Full Text Version
Author MSS
Abstract
There is a critical need for equitable access to cell therapies in cancer treatment, particularly within public safety-net healthcare systems that serve minority and socioeconomically disadvantaged populations. We discuss how the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine is piloting a cell therapy program aimed at addressing cancer care disparities and has the potential to serve as a national model for enhancing health equity in cancer care.
Keywords
Humans, Vulnerable Populations, Immunotherapy, Adoptive, Medically Underserved Area, Minority Groups
Published Open-Access
yes
Recommended Citation
Badr, Hoda; Rouce, Rayne; Scheurer, Michael E; et al., "Bringing Car T Cell Therapy Trials to Underserved Populations" (2023). Faculty and Staff Publications. 1604.
https://digitalcommons.library.tmc.edu/baylor_docs/1604